Satya Vani Nannapaneni, a member of the Promoter Group of Natco Pharma Limited, reported the sale of 45,000 equity shares on the open market. The transaction occurred on March 9, 2026. Following this disposal, the promoter group’s total holding in the company has decreased to 0.19% of the total share capital, down from the prior holding of 0.21%.
Insider Share Transaction Disclosure
A mandatory disclosure was made concerning a transaction executed by a key stakeholder in Natco Pharma Limited. Satya Vani Nannapaneni, identified as a Member of the Promoter Group, executed a sale of company equity shares.
Details of the Sale Transaction
The transaction involved the disposal of 45,000 equity shares, each with a face value of Rs. 2/-. The mode of transaction was explicitly identified as an Open Market sale. The date on which the trade was executed and the intimation received was March 9, 2026.
Shareholding Changes
The disclosure outlines the clear shift in the promoter’s stake:
- Holding Prior to Sale: The promoter group held 3,79,851 shares, representing 0.21% of the total share capital.
- Shares Sold: A total of 45,000 shares were sold.
- Holding Post-Sale: The resultant holding is 3,34,851 shares, equating to 0.19% of the total share capital.
The total equity share capital of Natco Pharma Limited remains consistent at 17,91,09,870 equity shares of Rs.2/- each before and after this acquisition/sale event.
Transaction Authorization
The disclosure document was signed by S.V. Nannapaneni, acting as the Seller/Authorized Signatory, dated March 11, 2026, from Illinois, USA.
Source: BSE
